Quest Historical Balance Sheet
DGX Stock | USD 175.41 1.35 0.78% |
Trend analysis of Quest Diagnostics Incorporated balance sheet accounts such as Other Current Liabilities of 672.5 M or Total Current Liabilities of 1.3 B provides information on Quest Diagnostics' total assets, liabilities, and equity, which is the actual value of Quest Diagnostics to its prevalent stockholders. By breaking down trends over time using Quest Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Quest Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Quest Diagnostics is a good buy for the upcoming year.
Quest Diagnostics Inventory |
|
Quest |
About Quest Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Quest Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Quest Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Quest Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Quest currently owns. An asset can also be divided into two categories, current and non-current.
Quest Diagnostics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Quest Diagnostics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Quest Diagnostics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Quest Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Quest Diagnostics Incorporated are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Quest Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Quest Diagnostics' Property Plant Equipment is fairly stable compared to the past year. Current Deferred Revenue is likely to rise to about 623.1 M in 2025, whereas Total Assets are likely to drop slightly above 8.8 B in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 4.6B | 5.5B | 6.9B | 7.3B | Total Assets | 12.8B | 14.0B | 16.2B | 8.8B |
Quest Diagnostics balance sheet Correlations
Click cells to compare fundamentals
Quest Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Quest Diagnostics balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 14.0B | 13.6B | 12.8B | 14.0B | 16.2B | 8.8B | |
Short Long Term Debt Total | 4.7B | 4.7B | 4.6B | 5.5B | 6.9B | 7.3B | |
Other Current Liab | 991M | 1.1B | 978M | 981M | 1.1B | 672.5M | |
Total Current Liabilities | 1.8B | 1.8B | 1.6B | 1.8B | 2.2B | 1.3B | |
Total Stockholder Equity | 6.8B | 6.4B | 5.9B | 6.3B | 6.8B | 4.0B | |
Property Plant And Equipment Net | 2.2B | 2.3B | 2.4B | 2.4B | 2.8B | 2.9B | |
Net Debt | 3.5B | 3.8B | 4.3B | 4.8B | 6.4B | 6.7B | |
Retained Earnings | 9.3B | 7.6B | 8.3B | 8.8B | 9.4B | 9.8B | |
Accounts Payable | 446M | 357M | 324M | 378M | 1.4B | 1.5B | |
Cash | 1.2B | 872M | 315M | 686M | 549M | 344.2M | |
Non Current Assets Total | 11.0B | 10.9B | 10.9B | 11.7B | 13.8B | 7.2B | |
Non Currrent Assets Other | 176M | 163M | 144M | 198M | 255M | 179.6M | |
Cash And Short Term Investments | 1.2B | 872M | 315M | 686M | 549M | 344.2M | |
Net Receivables | 1.5B | 1.4B | 1.2B | 1.2B | 1.3B | 911.0M | |
Liabilities And Stockholders Equity | 14.0B | 13.6B | 12.8B | 14.0B | 16.2B | 8.8B | |
Non Current Liabilities Total | 5.4B | 5.3B | 5.3B | 5.8B | 7.1B | 7.4B | |
Inventory | 223M | 208M | 192M | 190M | 188M | 107.5M | |
Other Current Assets | 157M | 223M | 196M | 286M | 351M | 233.2M | |
Other Stockholder Equity | (2.5B) | (2.5B) | (1.2B) | (2.4B) | (2.5B) | (2.4B) | |
Total Liab | 7.1B | 7.0B | 6.8B | 7.6B | 9.3B | 4.8B | |
Property Plant And Equipment Gross | 2.2B | 2.3B | 2.4B | 5.8B | 6.4B | 6.7B | |
Total Current Assets | 3.1B | 2.7B | 1.9B | 2.4B | 2.4B | 1.6B | |
Accumulated Other Comprehensive Income | (59M) | (39M) | (21M) | (14M) | (88M) | (92.4M) | |
Short Term Debt | 296M | 269M | 247M | 456M | 775M | 813.8M | |
Other Liab | 683M | 847M | 792M | 812M | 933.8M | 472.6M | |
Other Assets | 64M | 1.3B | 163M | 144M | 165.6M | 196.9M | |
Long Term Debt | 4.0B | 4.0B | 4.0B | 4.4B | 5.6B | 3.2B | |
Property Plant Equipment | 1.5B | 1.6B | 2.3B | 2.4B | 2.7B | 2.8B | |
Good Will | 6.9B | 7.1B | 7.2B | 7.7B | 8.9B | 5.8B | |
Treasury Stock | (5.2B) | (5.4B) | (3.5B) | (4.7B) | (4.2B) | (4.4B) | |
Net Tangible Assets | (1.6B) | (700M) | (1.8B) | (1.9B) | (2.1B) | (2.2B) | |
Noncontrolling Interest In Consolidated Entity | 46M | 50M | 39M | 37M | 42.6M | 34.3M | |
Retained Earnings Total Equity | 8.2B | 9.3B | 7.6B | 8.3B | 9.5B | 6.6B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.